NCT00834561View on ClinicalTrials.gov

Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

February 28, 2002

Study Completion Date

February 28, 2002

Conditions
Healthy
Interventions
DRUG

Lamotrigine

200 mg Tablet

DRUG

Lamictal®

200 mg Tablet

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834561 - Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions | Biotech Hunter | Biotech Hunter